Suscribirse

Care management of the agitation or aggressiveness crisis in patients with TBI. Systematic review of the literature and practice recommendations - 13/02/16

Doi : 10.1016/j.rehab.2015.11.001 
Jacques Luauté a, b, , David Plantier c, Laurent Wiart d, e, Laurence Tell a

the SOFMER group

a Service de médecine physique et de réadaptation, rééducation neurologique, hôpital Henry-Gabrielle, CHU de Lyon, 20, route de Vourles, 69230 Saint-Genis-Laval, France 
b Équipe Impact, Inserm, U1028, CNRS, UMR5292, centre de recherche en neuroscience de Lyon (CRNL), Lyon, France 
c Service de médecine physique et réadaptation, rééducation neurologique, hôpital René-Sabran, CHU de Lyon, 83400 Hyères, France 
d Cabinet de médecine physique et de réadaptation, 55, rue Eugène-Jacquet, 33000 Bordeaux, France 
e UEROS, service de médecine physique et de réadaptation, université Bordeaux-Segalen, CHU Pellegrin, 33076 Bordeaux cedex, France 

Corresponding author. Service de médecine physique et de réadaptation, rééducation neurologique, hôpital Henry-Gabrielle, CHU de Lyon, 20, route de Vourles, 69230 Saint-Genis-Laval, France.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

The agitation crisis in the awakening phase after traumatic brain injury (TBI) is one of the most difficult behavioral disorders to alleviate. Current treatment options are heterogeneous and may involve excessive sedation. Practice guidelines are required by professionals in charge of TBI patients. Few reviews were published but those are old and based on expert opinions. The purpose of this work is to propose evidence-based guidelines to treat the agitation crisis.

Methods

The elaboration of these guidelines followed the procedure validated by the French health authority for good practice recommendations, close to the Prisma statement. Guidelines were elaborated on the basis of a systematic and critical review of the literature.

Results

Twenty-eight articles concerning 376 patients were analyzed. Recommendations are: when faced with an agitation crisis, the management strategy implies to search for an underlying factor that should be treated such as pain, acute sepsis, and drug adverse effect (expert opinion). Physical restraints should be discarded when possible (expert opinion). Neuroleptic agent with a marketing authorization can be used in order to obtain a quick sedation so as to protect the patient from himself, closed ones or the healthcare team but the duration should be as short as possible (expert opinion). The efficacy of beta-blockers and antiepileptics with mood regulation effects like carbamazepine and valproate yield the most compelling evidence and should be preferably used when a background regimen is envisioned (grade B for beta-blocker and C for antiepileptics). Neuroleptics, antidepressants, benzodiazepines, buspirone may be prescribed but are considered second-line treatments (expert opinion).

Conclusion

This study provides a strategy for treating the agitation crisis based on scientific data and expert opinion. The level of evidence remains low and published data are often old. New studies are essential to validate results from previous studies and test new drugs and non-pharmaceutical therapies.

El texto completo de este artículo está disponible en PDF.

Keywords : Traumatic brain injury, Agitation crisis, Guideline, Aggressive behaviour, Treatment strategy


Esquema


© 2015  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 59 - N° 1

P. 58-67 - février 2016 Regresar al número
Artículo precedente Artículo precedente
  • Drugs for behavior disorders after traumatic brain injury: Systematic review and expert consensus leading to French recommendations for good practice
  • D. Plantier, J. Luauté, SOFMER group
| Artículo siguiente Artículo siguiente
  • Behavioral and affective disorders after brain injury: French guidelines for prevention and community supports
  • J. Luauté, J. Hamonet, P. Pradat-Diehl, SOFMER

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.